Delivery Order SPE2DB24D2208-SPE2DB24FHGSA

Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for 4564572050 REVATIO 20 MG Tablets to the Defense Logistics Agency (DLA). The $22,418.29 firm fixed-price contract has a completion date of May 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $82,808.59, is a delivery order with a firm fixed price and an ultimate completion date of December 20, 2024. The award is for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a ceiling value of $24,652.98 and a period of performance through May 2024. The award was made by the Defense Logistics Agency (DLA) and is not designated as a set-aside. The contract covers the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product used for cardiovascular health treatment. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the U.S. government. The contract, valued at $17,132.93, is a Delivery Order with a Firm Fixed Price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $15,530.12 firm fixed-price delivery order is for the provision of REVATIO 20 MG TABLET 90S, a medication, with a completion date of June 27, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Revatio 20 mg tablets. The contract, valued at $71,482.39, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 6, 2024 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award, valued at $22,344.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has a firm fixed-price pricing type and an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $17,589.92, is for the supply of Revatio 20 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medications and medical supplies to the U.S. government, including...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,969.29, is for the delivery of REVATIO 20 MG TABLET 90S. It is a firm fixed-price delivery order contract with a completion date of June 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $21,376.93 and is a firm fixed-price contract. There is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supports various government agencies and healthcare programs through its extensive federal contract awards. This delivery order is part of a larger Indefinite...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB24FHGSA
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a firm-fixed price Delivery Order with a ceiling value of $5,712.08 and an ultimate completion date of May 24, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 8/22/24, 3:25 PM